Novartis - History and Company profile (overview)
The Medicines Company's Alex Denner on Novartis deal to buy the company
Joe Jimenez, CEO of Novartis at Berkeley-Haas
The future of Novartis
Is Novartis Stock a Buy Now!? | Novartis (NVS) Stock Analysis! |
Novartis CEO discusses how AI will impact drug development
Novartis Stock Valuation --- $NVS
Novartis
Swiss pharma giant Novartis expects China to be its second biggest market by 2024
Novartis unlocks end-to-end supply chain visibility with RapidResponse
Novartis positioning is now best-suited for long-term gains and returns after spin-off, says CEO
Novartis areas of focus
Novartis - Breaking Barriers for Health Equity
Novartis/GSK -- expensive restructuring?
Novartis boss keeps faith in new cancer treatments
Novartis Social Business: Transforming primary healthcare in Asia
Novartis CEO Joe Jimenez: The best advice I ever got
Sandoz will be a long-term stable business if it can get its cost structure right, Novasecta says
How Sandoz Plans to Grow After Splitting from Novartis
